399 related articles for article (PubMed ID: 19008150)
1. Lymphatic filariasis elimination programme in India: progress and challenges.
Ramaiah KD
Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
[No Abstract] [Full Text] [Related]
2. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
Ranganath BG
J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
[No Abstract] [Full Text] [Related]
3. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
Sunish IP; Rajendran R; Mani TR; Dash AP; Tyagi BK
Lancet Infect Dis; 2006 Mar; 6(3):125-6. PubMed ID: 16500593
[No Abstract] [Full Text] [Related]
4. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
[No Abstract] [Full Text] [Related]
5. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
Nandha B; Krishnamoorthy K; Jambulingam P
Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
[TBL] [Abstract][Full Text] [Related]
6. Endpoints for lymphatic filariasis programs.
Grady CA; de Rochars MB; Direny AN; Orelus JN; Wendt J; Radday J; Mathieu E; Roberts JM; Streit TG; Addiss DG; Lammie PJ
Emerg Infect Dis; 2007 Apr; 13(4):608-10. PubMed ID: 17553278
[TBL] [Abstract][Full Text] [Related]
7. Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.
Wkly Epidemiol Rec; 2004 Oct; 79(40):358-65. PubMed ID: 15631012
[No Abstract] [Full Text] [Related]
8. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD
J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597
[TBL] [Abstract][Full Text] [Related]
9. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
Khan AM
Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
[No Abstract] [Full Text] [Related]
11. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
[TBL] [Abstract][Full Text] [Related]
12. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
[TBL] [Abstract][Full Text] [Related]
13. Filariasis elimination, Zanzibar.
Wkly Epidemiol Rec; 2001 Dec; 76(51-52):406-8. PubMed ID: 11789061
[No Abstract] [Full Text] [Related]
14. Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme.
Mukhopadhyay AK
J Vector Borne Dis; 2010 Mar; 47(1):55-7. PubMed ID: 20231775
[No Abstract] [Full Text] [Related]
15. Lymphatic filariasis and Brugia timori: prospects for elimination.
Fischer P; Supali T; Maizels RM
Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
[TBL] [Abstract][Full Text] [Related]
16. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
[TBL] [Abstract][Full Text] [Related]
17. The role of albendazole in programmes to eliminate lymphatic filariasis.
Ottesen EA; Ismail MM; Horton J
Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168
[TBL] [Abstract][Full Text] [Related]
18. Albendazole for mass drug administration to eliminate lymphatic filariasis.
Sabesan S
Lancet Infect Dis; 2006 Nov; 6(11):684-5. PubMed ID: 17067916
[No Abstract] [Full Text] [Related]
19. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
Babu BV; Kar SK
Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic filariasis: constraints ahead.
Mishra CP; Singh N
Indian J Public Health; 2003; 47(1):27-30. PubMed ID: 14723292
[No Abstract] [Full Text] [Related]
[Next] [New Search]
